Home About Us Management Product Pipeline Collaborators Contact Us

the Development of Placental Alkaline Phosphatase
for Cancer Cachexia and Bone Marrow Protection

Three-dimensional structure of Placental Alkaline Phosphatase

Our Mission

Provide recombinant Placental Alkaline Phosphatase (PLAP) for cancer patients to prevent muscle wasting and body weight loss (cachexia) as well as therapy induced deterioration of bone marrow function.

A Novel Concept For Cancer Treatment

In contrast to the prevailing view, our science strongly supports the view that to avoid or lessen cancer cachexia and maintain bone marrow health, treatment of patients with PLAP must start right after tumor detection along with the primary cancer treatment.